G. Mariani et al., Complete or incomplete percutaneous coronary revascularization in patientswith unstable angina in stent era: Are early and one-year results different?, CATHET C IN, 54(4), 2001, pp. 448-453
The aim of our study was to evaluate the impact of a strategy of incomplete
revascularization by PTCA, with or without stent implantation, on clinical
outcome of 208 consecutive patients (171 men) with unstable angina and mul
tivessel coronary artery disease. Mean age of the group was 63.8 +/- 10.3 y
ears (range, 31-91). Complete and incomplete revascularization was achieved
in 49 and 159 patients, respectively. A total of 226 stents were implanted
in 172 patients (1.31 +/- 0.65 stent per patient), equally distributed bet
ween the two groups. Left ventricular ejection fraction < 40% and total chr
onic coronary occlusions were significantly more frequent in patients with
incomplete revascularization than in those with complete (P = 0.014 and 0.0
01, respectively). In-hospital MACE occurred in 10% and 7.5% of patients wi
th complete and incomplete revascularization, respectively (P = NS). By mul
tivariate analysis, multiple stent implantation (OR, 5.44; 95% Cl, 1.21-24.
3), presence of thrombus in the treated lesion (OR, 6.3; 95% Cl, 1.53-25.9)
, Braunwald class III (OR, 4.74; 95% Cl, 1.08-20.8), and ad hoc PTCA (OR 4.
51; 95% Cl, 1.11-18.3) were significantly related to in-hospital outcome. A
t 1-year follow-up, 11.3% and 11.5% of patients with complete and incomplet
e revascularization, respectively, had MACE. In all patients, diabetes (OR,
3.40; 95% Cl, 1.09-10.58) and presence of thrombus in the treated lesion (
OR, 3.48; 95% Cl, 1.12-10.84) were significant predictors of 1-year outcome
by multivariate analysis. These results indicate that the strategy of inco
mplete revascularization in unstable angina patients with multivessel coron
ary disease does not expose them to a higher risk of death or other major i
schemic events in comparison to those undergoing complete revascularization
. (C) 2001 Wiley-Liss, Inc.